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Fused pyrimidines are found in a variety of natural products (e.g., purines, pyrro-
lopyrimidines, pyridopyrimidines, pteridines), agrochemicals and veterinary products
(1–3). Pyrimidine derivatives and heterocyclic annelated pyrimidines continue to attract
great interest due to the wide variety of interesting biological activities observed for
these compounds, such as anticancer (4), antiviral (5), antitumor (6), anti-inflammatory
(7), antimicrobial (8), antifungal (9), antihistaminic (10) and analgesic (11) activities. Aro-
matic and heteroaromatic compounds bearing an o-aminonitrile or o-aminoester group
are useful substrates for the preparation of various condensed pyrimidine heterocyclic
systems (12). In view of these reports and as continuation of our earlier studies (13–16),
the synthesis of a new series of thieno-pyrimidine derivatives is now reported. Several
compounds were screened for their antimicrobial activity.
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Reaction of heteroaromatic o-aminonitrile with ethyl N-
-bis(methylthio)methyleneamino acetate resulted in an-
nelation of a thieno3,2-eimidazo1,2-cpyrimidine moiety
in a one step process. 1,2,4Triazolo4,3-cthieno- 3,2-epy-
rimidine derivatives were prepared by initial treatment
of o-aminonitrile with carbon disulfide, followed by me-
thylation with methyl iodide and subsequent reaction
with benzhydrazide and thiosemicarbazide, respectively.
Hydrazinothieno2,3-dpyrimidine was prepared by cycli-
zation of heteroaromatic o-aminoester with formamide, fol-
lowed by chlorination and subsequent displacement with
hydrazine. Treatment of the hydrazino derivative with
acetylacetone, benzaldehyde and acetic anhydride afford-
ed pyrazolylpyrimidine, benzylidenehydrazonopyrimidine
and triazolopyrimidine derivatives, respectively. Some of
these derivatives exhibited pronounced antimicrobial ac-
tivity.
Keywords: imidazopyrimidine, triazolopyrimidine, anti-
microbial activity
* Correspondence, e-mail: mosharef65@yahoo.com
EXPERIMENTAL
Melting points were determined on an electrothermal apparatus in an open capil-
lary tube and are uncorrected. The 1H and 13C NMR spectra were measured on a Bruker
AC 200 spectrophotometer (Germany) using DMSO-d6 or CDCl3 as the solvent and che-
mical shifts were expressed as  values in ppm against TMS as an internal standard. TLC
using silica gel G60 (Merck, Germany) routinely checked the purity of the compounds
and the spots were exposed in iodine vapour for visualization.
Syntheses
The starting materials, 2-amino-4,5,6,7-tetrahydrobenzothiophen-3-carbonitrile (1)
and ethyl 2-amino-4,5,6,7-tetrahydrobenzothiophen-3-carboxylate (8), were prepared by
condensation of cyclohexanone, elemental sulfur and malononitrile or ethyl cyanoace-
tate as described (17). The annelating reagent, ethyl N-bis(methylthio)methyleneamino
acetate (2) was prepared according to the literature procedure (18).
5-Methylthio-8,9,10,11-tetrahydrobenzothieno3,2-eimidazo1,2-cpyrimidin-2(3H)-one (3). –
A solution of o-aminonitrile 1 (0.01 mol) and annelating reagent 2 (0.01 mol) in dry acetic
acid (10 mL) was refluxed for 8 h. The solution was then poured onto ice-water under
constant stirring and the product was extracted with chloroform. After solvent evapora-
tion, the obtained solid was recrystallized from ethanol to give 3 as colourless crystals.
2,4-Dimethylthio-5,6,7,8-tetrahydrobenzothieno2,3-dpyrimidine (5). – To a solution of o-
-aminonitrile 1 (0.01 mol) in pyridine (4 mL), carbon disulfide (0.05 mol) was added and
the mixture was heated on a water-bath for 8 h. After cooling, ethanol was added to the
mixture and the separated solid was collected by filtration, washed with ether to give
tetrahydrobenzothieno2,3-dpyrimidine-2,4(1H,3H)-dithione (4). Methyl iodide (0.02 mol)
was added dropwise to the crude product 4 in aqueous NaOH (10 mL) and stirred at
room temperature for 12 h. The obtained yellowish solid was collected and recrystal-
lized from ethanol to give 5 as yellow crystals.
5-Methylthio-3-phenyl-8,9,10,11-tetrahydro1,2,4triazolo4,3-cbenzothieno3,2-epyrimi-
dine (6). – A mixture of 5 (0.01 mol) and benzhydrazide (0.01 mol) in pyridine (10 mL)
was refluxed for 14 h. The mixture was concentrated in vacuum and was then allowed
to set in the refrigerator for 6 h. The separated solid was recrystallized from ethanol to
give 6 as yellow crystals.
3-Amino-5-methylthio-8,9,10,11-tetrahydro1,2,4 triazolo4,3-cbenzothieno3,2-epyrimi-
dine (7). – Amixture of 5 (0.01 mol) and thiosemicarbazide (0.01 mol) in pyridine (10 mL)
was refluxed for 14 h. The separated solid was collected and recrystallized from ethanol
to give 7 as yellow crystals.
5,6,7,8-Tetrahydrobenzothieno2,3-dpyrimidin-4(3H)-one (9). – A solution of o-amino es-
ter 8 (0.01 mol) and formamide (10 mL) was refluxed for 4 h. The precipitated product
was collected and recrystallized from ethanol to give 9 as yellow crystals.
4-Chloro-5,6,7,8-tetrahydrobenzothieno2,3-dpyrimidine (10). – A mixture of pyrimido-
ne 9 (0.05 mol) and thionyl chloride (20 mL) was refluxed for 4 h. After cooling, the mix-
ture was poured onto ice-water and stirred for another 30 min. The separated solid was
recrystallized from dioxane to give 10 as yellow crystals.
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4-Hydrazino-5,6,7,8-tetrahydrobenzothieno2,3-dpyrimidine (11). – A mixture of chloro
compound 10 (0.05 mol) and hydrazine hydrate (3 mL) in dioxane (30 mL) was refluxed
for 2 h. The separated solid was filtered off and recrystallized from dioxane to give 11 as
yellow crystals.
4-Benzylidenehydrazono-5,6,7,8-tetrahydrobenzothieno2,3-dpyrimidine (12). – A mixtu-
re of hydrazino compound 11 (0.01 mol) and benzaldehyde (0.01 mol) in acetic acid (5
mL) was refluxed for 1 h. The separated solid was filtered off and recrystallized from
ethanol to give 12 as white crystals.
4-(3,5-Dimethylpyrazolyl)-5,6,7,8-tetrahydrobenzothieno2,3-dpyrimidine (13). – A mixtu-
re of hydrazino compound 11 (0.01 mol) and acetylacetone (1 mL) in ethanol (20 mL)
was refluxed for 8 h. The separated solid was recrystallized from ethanol to give 13 as
pale brown crystals.
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3-Methyl-8,9,10,11-tetrahydrobenzothieno3,2-e1,2,4triazolo4,3-cpyrimidine (14). – A mix-
ture of hydrazino compound 11 (0.01 mol) and acetic anhydride (2 mL) was refluxed for
6 h. After cooling the mixture was poured onto ice-water and extracted with ether and
the solvent was evaporated. The obtained solid was recrystallized from ethanol to give
14 as yellow crystals.
4-Oxo-5,6,7,8-tetrahydrobenzothieno2,3-dpyrimidine-3-methyl sulfonate ester (15) or 4-
-oxo-5,6,7,8-tetrahydrobenzothieno2,3-dpyrimidine-3-phenyl sulfonate ester (16). – A mixture
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Table II. Spectral data of the prepared compounds
Compd.
No.
1H NMR (, ppm) (DMSO-d6/CDCl3)
13C NMR (, ppm) (DMSO-d6/CDCl3)
3 4.22 (s, 2H, CH2), 2.89 (m, 4H, 2CH2),
2.71 (s, 3H, SCH3), 1.86 (m, 4H, 2CH2)
183.4, 165.6, 164.7, 152.9, 134.5, 130.5,
115.1, 49.5, 29.7, 25.2, 22.8, 22.0, 14.1
5 2.65 (s, 3H, SCH3), 2.61 (s, 3H, SCH3),
2.49 (m, 8H, 4CH2)
165.2, 163.1, 133.7, 130.8, 126.8, 124.1,
39.9, 25.9, 24.8, 21.7, 13.6, 12.0
6 7.92 (m, 2H, Ar-H), 7.54 (m, 3H, Ar-H),
3.48 (m, 8H, 4CH2), 2.49 (s, 3H, SCH3)
167.3, 147.5, 140.7, 135.5, 134.0, 128.8,
128.6, 127.5, 126.7, 123.0, 34.9, 33.5, 26.2,
24.7, 18.6
7 2.48 (m, 8H, 4CH2), 2.43 (s, 3H, SCH3),
1.78 (bs, 2H, NH2).
165.2, 165.0, 163.2, 133.8, 126.9, 124.1,
106.8, 26.0, 24.9, 21.9, 13.7, 12.2
9 12.1 (bs, 1H, NH), 7.94 (s, 1H, 2-H), 3.0
(t, 2H, 8-H), 2.77 (t, 2H, 5-H), 1.87 (m,
4H, 6- and 7-H)
168.2, 161.0, 143.5, 142.8, 133.9, 130.8, 34.6,
30.9, 24.7, 18.4
10 7.61 (s, 1H, 2-H), 3.0 (t, 2H, 8-H), 2.74
(t, 2H, 5-H), 1.85 (m, 4H, 6- and 7-H)
158.4, 140.8, 133.6, 128.2, 123.0, 34.9,
26.1, 23.5
11 7.84 (s, 1H, 2-H), 5.35 (s, 1H, NH), 4.23
(t, 2H, 5-H), 3.71 (t, 2H, 8-H), 3.03 (br,
2H, NH2), 2.10 (m, 4H, 6- and 7-H)
166.9, 154.3, 140.7, 133.8, 128.2, 123.1,
35.0, 25.9, 24.0
12 8.67 (s, 1H, =CH), 7.86 (s, 1H, 2-H), 7.76
(m, 5H, Ph), 5.35 (s, 1H, NH), 4.20 (t, 2H,
5-H), 3.78 (t, 2H, 8-H), 1.80 (m, 4H, 6-
and 7-H)
165.7, 162.1, 146.4, 133.3, 131.3, 130.4,
128.8, 128.6, 127.2, 82.2, 30.5, 29.6, 27.6,
26.9
13 8.19 (s, 1H, 2-H), 5.28 (s, 1H, 4’-H), 3.98
(s, 3H, CH3), 3.76 (s, 3H, CH3), 3.70 (t,
2H, 5-H), 3.48 (t, 2H, 8-H), 1.86 (m, 4H,
6- and 7-H)
166.5, 160.3, 145.4, 138.9, 132.2, 130.3,
127.2, 121.4, 30.1, 29.7, 21.6, 16.5, 11.9
14 8.10 (s, 1H, 6-H), 3.95 (m, 4H, 9- and
10-H), 3.66 (m, 4H, 8- and 11-H), 1.20
(s, 3H, CH3)
172.2, 171.0, 170.1, 168.0, 166.8, 131.3,
129.6, 30.0, 28.5, 24.8, 20.8, 20.5
15 8.34 (s, 1H, 2-H), 2.80 (t, 2H, 5-H), 2.60
(t, 2H, 8-H), 1.80 (m, 4H, 6- and 7-H),
1.20 (s, 3H, CH3)
169.5, 162.8, 143.8, 142.7, 134.6, 131.6,
36.9, 34.6, 33.2, 25.8, 19.1
16 8.42 (s, 1H, 2-H), 7.54 (m, 5H, Ph), 2.83
(t, 2H, 8-H), 2.62 (t, 2H, 5-H), 1.82 (m,
4H, 6- and 7-H)
169.3, 162.5, 143.6, 142.4, 138.5, 134.8,
131.6, 130.9, 128.4, 125.0, 35.1, 34.3, 25.1,
19.3
of 9 (0.01 mol) and methanesulfonyl chloride (0.015 mol) or benzenesulfonyl chloride
(0.015 mol) in pyridine (5 mL) was stirred at room temperature for 6 h. The mixture was
poured onto ice-water, neutralized with 10% HCl and extracted with chloroform. The
solvent was removed under reduced pressure and the separated solid was recrystallized
from ethanol to give 15 or 16.
Structures 3, 5–7, 9–16 were established by elemental analysis, 1H NMR and 13C NMR
spectral data (Tables I and II).
Antimicrobial activity
Some of the synthesized compounds (3, 6, 7, 9–14) were screened for antibacterial
activity against pathogenic organisms; Bacillus cereus (BTCC 19), Shigella dysenteriae (AE
14396) and Salmonella typhi (AE 14612) (Table III) and for antifungal activity against Mac-
rophomina phaseolina (Tassi) Goid, Fusarium equiseti (Corda) Sacc, Alternaria alternata (Fr.)
Kedissler and Collectotrichum corchori Ikata (Yoshida) (Table IV). The disc diffusion me-
thod (19) and poisoned-food techniques (20) were used for antibacterial and antifungal
activities, respectively.
The tested compounds were dissolved in N,N-dimethylformamide (DMF) to get a
solution of 1 mg mL–1. The inhibition zones were measured in millimeters at the end of
an incubation period of 48 h at 28 C. DMF alone showed no inhibition zone. Nutrient
agar (NA) and potato dextrose agar (PDA) were used as basal media to test the bacteria
and fungi, respectively. Commercial antibacterial ampicillin and antifungal nystatin were
also tested under similar conditions for comparison.
RESULTS AND DISCUSSION
Reaction of o-aminonitrile 1 with ethyl N-bis(methylthio)methyleneamino acetate
(2) gave double annelated product, 5-methylthio-8,9,10,11-tetrahydrobenzothieno3,2-e-
-imidazo1,2-cpyrimidin-2(3H)-one (3), in one-pot reaction (Scheme 1). The structure of 3
was established by its elemental analysis and compatible spectroscopic data. The 1H NMR
spectrum of 3 exhibited a two-proton singlet for CH2 at  4.22 ppm, a three-proton sin-
glet for SCH3 at  2.71 ppm. The 13C NMR spectrum displayed signals at  183.4 ppm for
C=O carbon and at  49.5 ppm for methylene carbon at position C-3 of the molecule. The
rest of the spectrum was in good agreement with the structure 3. Compound 1 was read-
ily cyclized to the corresponding tetrahydrobenzothieno2,3-dpyrimidine-2,4(1H,3H)-
-dithione (4) upon treatment with CS2 in refluxing pyridine. Methylation of the dithione
4 with MeI in aqueous NaOH afforded compound 2,4-dimethylthio-5,6,7,8-tetrahydro-
benzothieno2,3-dpyrimidine (5). The 1H and 13C NMR spectra of product 5 were com-
patible with the proposed structure.
The reaction of 5 with benzhydrazide in boiling pyridine gave the cyclized product
5-methylthio-3-phenyl-8,9,10,11-tetrahydro1,2,4triazolo4,3-cbenzothieno3,2-epyrim-
idine (6). Also, treatment of 5 with thiosemicarbazide led to the formation of 3-amino-
-5-methylthio-8,9,10,11-tetrahydro1,2,4triazolo4,3-cbenzothieno3,2-epyrimidine (7).
The structures of 6 and 7 were established by their compatible spectral data.
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Refluxing of o-aminoester 8 with formamide afforded 5,6,7,8-tetrahydrobenzothi -
eno2,3-dpyrimidin-4(3H)-one (9) (Scheme 2). Chlorination of 9 with thionyl chloride
gave 4-chloro-5,6,7,8-tetrahydrobenzothieno2,3-dpyrimidine (10), while, acylation of 9
with methanesulfonyl chloride or benzenesulfonyl chloride furnished the corresponding
4-oxo-5,6,7,8-tetrahydrobenzothieno2,3-dpyrimidine-3-methyl sulfonate ester (15) or 4-
-oxo-5,6,7,8-tetrahydrobenzothieno2,3-dpyrimidine-3-phenyl sulfonate ester (16). The
structures of 9, 10, 15 and 16 were established from their respective elemental and spec-
tral data.
The chlorine group of 10 underwent nucleophilic displacement by reflux with
hydrazine hydrate in dioxane to produce 4-hydrazino-5,6,7,8-tetrahydrobenzothieno-
-2,3-dpyrimidine (11), which was condensed with benzaldehyde to give 4-benzylidene-
hydrazono-5,6,7,8-tetrahydrobenzothieno2,3-dpyrimidine (12). Similarly, heating 11
with acetylacetone produced the corresponding 4-(3,5-dimethylpyrazolyl)pyrimidine
derivative (13). Furthermore, upon boiling compound 11 in acetic anhydride, the cyc-
lized product 3-methyl-8,9,10,11-tetrahydrobenzothieno3,2-e1,2,4triazolo4,3-cpyri-
midine (14) was formed. Assignments of the structures of 12–14 to the proposed reaction
products are based on elemental and spectral data.
Amongst the compounds 3, 6, 7, 9–14 screened for antimicrobial activity, compound 13
showed the highest activity against all bacteria. It exhibited stronger activity than ampicillin
also towards B. cereus and S. typhi. It was followed by compound 3, which showed the highest
activity against B. cereus and S. typhi. As far as antifungal activity is concerned, all compounds
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Table III. Antibacterial activity of some synthesized compounds
Zone of inhibition (mm)a
Compd. B. cereus S. dysenteriae S. typhi
3 20 13 26
6 8 – 8
7 10 6 –
9 10 – 12
10 11 14 11
11 9 12 15
12 19 18 17
13 31 28 29
14 15 7 15
Ampicillin 21 30 24
– no inhibition.
a 1 mg mL–1 per disc
DMF – negative control
showed good to excellent activity against all the fungi. Compounds 3 and 13 exhibited even
stronger activity than nystatin against A. alternata and C. corchori, compounds 7 and 12
against M. phaseolina, compounds 7, 13 and 14 against F. equiseti. Compounds 6, 7, 9–12 and
14 were either inactive or moderately to fairly active against the tested bacteria whereas
compounds 6, 9–11 exhibited good to excellent results against all the fungi. Introduction of
imidazo (3) or pyrazolo (13) moiety to the pyrimidine derivatives might be responsible for
antimicrobial activity enhancement of these compounds.
CONCLUSIONS
The structure activity relationship suggested that fused pyrimidines containing imi-
dazo (3) and pyrazolo (13) rings showed higher antibacterial and antifungal activities
than the corresponding other moieties (like triazolo, halo, sulfonyl groups). These find-
ings encourage us to explore other molecules by introducing these potent moieties into
other fused heterocycles such as furano- and pyridopyrimidines. Our prediction is that
these compounds with new ring systems may show even better antimicrobial activities.
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S A @ E T A K
Sinteza i antimikrobno djelovanje novih derivata tienopirimidina
MD. MOSHAREF HOSSAIN BHUIYAN, KHANDKER MD. MIZANUR RAHMAN, MD. KAMRUL HOSSAIN,
ABDUR RAHIM, MOHAMMED ISMAIL HOSSAIN i MOHAMMAD ABU NASER
Reakcijom heteroaromatskih o-aminonitrila s etil N-bis(metiltio)metilenamino ace-
tatom u jednom sintetskom koraku do{lo je do anelacije u tieno3,2-eimidazo1,2-cpi-
rimidin. Derivati 1,2,4triazolo4,3-ctieno3,2-epirimidina pripravljeni su reakcijom
o-aminonitrila s ugljikovim disulfidom, te metilacijom s metil-jodidom i naknadnom
reakcijom s benzhidrazidom, odnosno tiosemikarbazidom. Hidrazinotieno2,3-dpirimi-
din je pripravljen ciklizacijom heteroaromatskog o-aminoestera s formamidom, te klo-
riranjem i supstitucijom s hidrazinom. Reakcijom hidrazinskog derivata s acetilacetonom,
benzaldehidom ili anhidridom octane kiseline nastali su derivati pirazolilpirimidina,
benzilidenehidrazonopirimidina, odnosno trizolopirimidina. Neki od tih derivata djelu-
ju antimikrobno.
Klju~ne rije~i: imidazopirimidin, triazolopirimidin, antimikrobno djelovanje
Department of Chemistry, University of Chittagong, Chittagong-4331, Bangladesh
450
M. H. Bhuiyan et al.: Synthesis and antimicrobial evaluation of some new thienopyrimidine derivatives, Acta Pharm. 56 (2006) 441–450.
